Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,083 | 1,805 | 2,010 | 2,835 | 3,991 |
| Marketable Securities | 793 | 797 | 768 | 760 | 153 |
| Receivables | 123 | 119 | 491 | 452 | 118 |
| TOTAL | $2,020 | $2,749 | $3,300 | $4,057 | $4,286 |
| Non-Current Assets | |||||
| PPE Net | 252 | 229 | 182 | 176 | 87 |
| TOTAL | $252 | $229 | $182 | $176 | $87 |
| Total Assets | $2,272 | $2,978 | $3,482 | $4,233 | $4,373 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 401 | 320 | 355 | 325 | 207 |
| TOTAL | $401 | $449 | $689 | $831 | $529 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 129 | 335 | 505 | 323 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $401 | $449 | $689 | $831 | $529 |
| Shareholders' Equity | |||||
| Common Shares | 26,538 | 26,778 | 25,760 | 25,680 | 25,410 |
| Retained earnings | -28,648 | -28,127 | -26,616 | -25,665 | -24,865 |
| Other shareholders' equity | 779 | 786 | 760 | 754 | 746 |
| TOTAL | $1,871 | $2,529 | $2,793 | $3,402 | $3,844 |
| Total Liabilities And Equity | $2,272 | $2,978 | $3,482 | $4,233 | $4,373 |